Is routine scanning for deep-vein thrombosis necessary following endovenous laser ablation and ultrasound-guided sclerotherapy? A statistical perspective in Australian Phlebology practice

2011 ◽  
Vol 26 (2) ◽  
pp. 49-51 ◽  
Author(s):  
S McMaster
2019 ◽  
Vol 35 (5) ◽  
pp. 325-336
Author(s):  
Kurosh Parsi ◽  
Brydon Panozzo ◽  
Alison Bull ◽  
Anes Yang ◽  
Mina Kang ◽  
...  

Objectives The aim of sclerotherapy is to induce fibrosclerosis of superficial veins. We postulated that inadvertent entry of sclerosants into deep veins can result in sclerotic occlusion, deep vein sclerosis, a non-thrombotic process distinct from spontaneous deep vein thrombosis. The aim of this study was to assess the role of d-dimer in differentiating between deep vein sclerosis and deep vein thrombosis. Methods Proximal trunks of great and small saphenous veins were treated with endovenous laser ablation. Venous tributaries and perforators were treated with foam ultrasound guided sclerotherapy. Ultrasound studies of lower limb deep veins were performed before and one week after the procedures, to detect deep vein occlusions (DVOs). d-dimer levels were measured for DVOs and long-term ultrasound studies monitored the recanalisation rates. Results In a six-year period, 9143 procedures were performed in 1325 patients for bilateral varicose veins. This included 1124 endovenous laser ablation and 8019 foam ultrasound guided sclerotherapy procedures. A total of 259 DVOs (2.83%) were identified on ultrasound which included 251 deep vein sclerosis (2.74%), seven deep vein thrombosis (0.07%) and one endovenous heat-induced thrombosis (EHIT, 0.08%). d-dimer values <0.5 µg/mL excluded deep vein thrombosis s, 0.5–1.0 µg/mL were more likely to be associated with deep vein sclerosis and >1.0 µg/mL were a more likely to be associated with deep vein thrombosis. Lower sclerosant concentrations and higher foam volumes were associated with increased risk of DVO ( p <  .0001). No significant relationship was found between DVO and gender or thrombophilia. Deep vein thrombosis and EHIT cases but not deep vein sclerosis patients were anticoagulated. None had thromboembolic complications. Patients were followed up for a median of 299 days (37–1994 days). Recanalisation rates were 71.1% for deep vein sclerosis (92.3% competent) and 71.4% for deep vein thrombosis (60.0% competent). Conclusions Deep vein sclerosis is a relatively benign clinical entity distinct from deep vein thrombosis and does not require anticoagulation. Majority of affected veins on long-term follow-up regain patency and competence. d-dimer can be used to assist in differentiating deep vein sclerosis from deep vein thrombosis.


2017 ◽  
Vol 13 (3) ◽  
pp. 317-326
Author(s):  
Zbigniew Krasiński ◽  
◽  
Krzysztof Aniukiewicz ◽  
Aleksandra Krasińska ◽  
Beata Krasińska ◽  
...  

2015 ◽  
Vol 26 (4) ◽  
pp. 293-296
Author(s):  
Yuki Orimoto ◽  
Hiroyuki Ishibashi ◽  
Ikuo Sugimoto ◽  
Tetsuya Yamada ◽  
Yuki Maruyama ◽  
...  

2020 ◽  
Vol 62 ◽  
pp. 45-50.e2 ◽  
Author(s):  
Nathan K. Itoga ◽  
Kara A. Rothenberg ◽  
Celine Deslarzes-Dubuis ◽  
Elizabeth L. George ◽  
Venita Chandra ◽  
...  

2009 ◽  
Vol 96 (S1) ◽  
pp. 10-10 ◽  
Author(s):  
R. J. Winterborn ◽  
F. Taiwo ◽  
F. J. A. Slim ◽  
M. R. Whyman ◽  
K. R. Poskitt

2013 ◽  
Vol 85 (6) ◽  
pp. 614
Author(s):  
You Shin Kim ◽  
Byung Sihk Kim ◽  
Sang-Ki Lee ◽  
Jae gon Lee ◽  
Yonggu Lee ◽  
...  

2013 ◽  
Vol 1 (3) ◽  
pp. 231-238 ◽  
Author(s):  
Sachin R. Kulkarni ◽  
David E. Messenger ◽  
Fiona J.A. Slim ◽  
Lorraine G. Emerson ◽  
Richard A. Bulbulia ◽  
...  

2007 ◽  
Vol 107 (1) ◽  
pp. 181-182 ◽  
Author(s):  
Dimitrios Karakitsos ◽  
Theodosios Saranteas ◽  
Alexandros P. Patrianakos ◽  
Nicolaos Labropoulos ◽  
Andreas Karabinis

Sign in / Sign up

Export Citation Format

Share Document